title: "Diving into the dark matter of the cancer genome".
Imperial College, London, UK
department of Surgery and Cancer
Imperial Centre for Translational and Experimental Medicine
EU H2020 EpiPredict consortium (www.epipredict.eu/)
Recent years have seen an increasing effort to decode the cancer genome. Most of the studies have focused on the coding genome to identify cancer driver genes. My group is interested in the role of the non-coding genome and its potential contribution to the drive transcriptional aberrations in breast cancer patients. To do so we use a wide-spectrum of techniques including genomic, epigenomics in patient-derived samples. I will present the results of a couple of studies in which mapping the non-coding genome using epigenomic has yield novel insights on breast cancer progression in luminal breast cancer.
Science Park 904
Science Park 904 | 1098 XH AmsterdamGo to detailpage
+31 (0)20 525 8626
dr. P.J. (Pernette) Verschure
P.J.Verschure@uva.nl | T: 0205255151Go to detailpage